The effect of the angiotensin-converting enzyme inhibitor Capoten on the volume-regulation indices of patients with stage-Ii hypertension
Vladkovs'kyĭ, I.K.; Plesh, I.A.; Haĭdukov, V.A.; Loboda, M.I.
Likars'ka Sprava 1996(3-4): 113-117
1996
ISSN/ISBN: 1019-5297 PMID: 9035842 Document Number: 469145
Document emailed within 1 workday
Related Documents
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Karpov, I.A.; Deev, A.D. 2003: Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension Kardiologiia 43(6): 28-32
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A. 2003: Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension Kardiologiia 43(10): 66-71
Pavliukova, E.N.; Bakhmet'eva, T.A.; Puzyrev, K.V.; Karpov, R.S. 2006: Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril Kardiologiia 46(9): 19-25
Ryan, E.; Muldowney, F.P. 1983: Use of angiotensin i to Ii converting enzyme inhibitor S.Q. 14225 (captopril), in moderate essential hypertension Irish Medical Journal 76(4): 175; 177-178
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Hamada, M.; Hara, Y.; Ohtsuka, T.; Suzuki, J.; Saeki, H.; Ogimoto, A.; Shigematsu, Y. 2003: Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor Journal of Cardiovascular Pharmacology 41(Suppl 1): S5-10
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Fagard, R.; Amery, A.; Lijnen, P.; Staessen, J. 1980: First dose effect of the oral angiotensin converting enzyme inhibitor captopril Archives Internationales de Pharmacodynamie et de Therapie Suppl: 178-187
Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38
Mizuno, K.; Hashimoto, S.; Kunii, N.; Tani, M.; Niimura, S.; Yabe, R.; Watari, H.; Fukuchi, S. 1985: Acute effects of the new oral angiotensin converting enzyme inhibitor 1-(D-3-acetylthio-2-methylpropanoyl)-L-prolyl-L-phenylalanine (Alacepril) in essential hypertension Research Communications in Chemical Pathology and Pharmacology 49(2): 175-187
Al-Omran, M.; Lindsay, T.F. 2005: Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor? Canadian Journal of Cardiology 21(2): 189-193
Schiffrin, E.L.; Deng, L.Y.; Larochelle, P. 1994: Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension Archives des Maladies du Coeur et des Vaisseaux 87(8): 979-981
Paul, L.C.; Davidoff, A.; Benediktsson, H. 1994: Cardiac allograft atherosclerosis in the rat. the effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor Transplantation 57(12): 1767-1772
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620